Overview

Diabetic Peripheral Neuropathic Pain (DPNP)

Status:
Completed

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the efficacy of study drug (BMS-954561) as compared to placebo in the treatment of patients with diabetic peripheral neuropathic pain (DPNP).

Phase:

Phase 2

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Pregabalin